Awareness overview
NSCLC awareness: Connecting diagnosis, stage, and treatment planning
A framework for understanding why a precise diagnosis and a clear picture of disease extent matter in non-small cell lung cancer.
A diagnosis with important distinctions
Non-small cell lung cancer encompasses several histologic types, including adenocarcinoma and squamous cell carcinoma. Establishing the diagnosis is the beginning of treatment planning. Histology, stage, molecular findings, and the patient’s overall condition help define the decisions that follow.
Stage provides essential context
The extent of disease influences the role of surgery, radiation therapy, and systemic treatment. Early-stage and advanced disease present different clinical questions. Multidisciplinary discussion can help bring diagnostic findings and treatment options into a coherent plan.
Making information useful
An awareness conversation should help clarify what is already known and what remains to be established. Reviewing pathology, staging, and pending test results together supports informed discussion of the next step. The NCI’s professional PDQ summary provides a detailed, regularly maintained reference for stage-specific treatment approaches.
Source: National Cancer Institute — Non-small cell lung cancer treatment (PDQ).